ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CVSG Cvs Group Plc

975.00
-44.00 (-4.32%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -44.00 -4.32% 975.00 976.00 984.50 1,040.00 980.00 1,040.00 488,057 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Veterinary Svcs-animal Specs 608.3M 41.9M 0.5843 16.81 704.58M
Cvs Group Plc is listed in the Veterinary Svcs-animal Specs sector of the London Stock Exchange with ticker CVSG. The last closing price for Cvs was 1,019p. Over the last year, Cvs shares have traded in a share price range of 950.00p to 2,226.00p.

Cvs currently has 71,712,970 shares in issue. The market capitalisation of Cvs is £704.58 million. Cvs has a price to earnings ratio (PE ratio) of 16.81.

Cvs Share Discussion Threads

Showing 301 to 322 of 950 messages
Chat Pages: Latest  14  13  12  11  10  9  8  7  6  5  4  3  Older
DateSubjectAuthorDiscuss
23/9/2015
12:58
I will be adding further on any tangible dip, a pause for breath is to be expected.
lomax99
23/9/2015
10:29
gargleblaster, Thanks, that sounds about right.
I am invested in CVSG.

Eno

eno nedlog
22/9/2015
21:20
eno - I think it is a case of a company having tremendous growth but bumping against a full valuation (22.2X fwd earnings) - hence the period of consolidation. If you have the patience you should be rewarded imv, but dyor etc.
gargleblaster
22/9/2015
12:44
Is this sideways move of the share price due to its overeaching itself in March April and June?
Or just pacing with the rest of the market?

Eno

eno nedlog
28/8/2015
10:59
Does anyone have any info on this share?TIA
lollipop3
29/7/2015
12:08
Support around the 600p mark?
mrmediumterminvestor
27/7/2015
09:48
Investorschamp - takeover - by who?? Pets at Home already have a massive debt millstone around their neck. Who are the other candidates?? Glib comment imv.
gargleblaster
27/7/2015
08:22
Sound TU imv. In line, and like for like's up 6.8%. Market seems okay with that. Am happy to hold long term!
gargleblaster
23/7/2015
19:11
Looking to add a few more.......
lomax99
23/7/2015
15:00
Seems to be falling from grace, no news making shareholders bored, will wait and watch alittle longer as I hope its bottomed out
farmsted
03/6/2015
17:21
Indeed indeed.
mike740
03/6/2015
16:35
Seems to be making a habit of "the late charge"!
gargleblaster
03/6/2015
16:21
CVSG

Lovely strong finish today. The next leg up truely well on its way.

mike740
03/6/2015
08:08
CVSG: interesting to note one brokers share price TARGET........

07 May Berenberg Buy 663.50 560.00 730.00 Reiterates

730p.

mike740
02/6/2015
20:35
CVSG looks rather dear until you take into account that EPS growth here is at a cracking rate. If investors bought while P/E was 50 plus why shouldnt they Buy whilst P/E is at forecasts of half of that. People spend a lot of money on there Pets.

CVS Group PLC

FORECASTS


2015 2016
Date Rec Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p)

N+1 Singer
01-06-15 CORP 17.60 22.80 3.00 19.73 25.50 4.00
Peel Hunt LLP
29-05-15 BUY 18.83 25.52 3.00 20.62 27.62 3.50
Investec Securities
09-04-15 BUY 17.90 23.63 2.88 20.20 26.50 3.16

2015 2016
Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p)
Consensus 17.90 23.63 3.00 20.20 26.50 3.50
1 Month Change 0.15 0.00 0.00 0.00 0.00 0.00
3 Month Change 1.18 2.10 0.00 1.70 2.58 0.00

GROWTH
2014 (A) 2015 (E) 2016 (E)
Norm. EPS 18.69% 172.49% 12.16%
DPS 33.33% 50.00% 16.67%

INVESTMENT RATIOS
2014 (A) 2015 (E) 2016 (E)

EBITDA £18.30m £22.63m £25.48m
EBIT £8.20m £m £m
Dividend Yield 0.31% 0.46% 0.54%
Dividend Cover 4.34x 7.88x 7.57x
PER 75.42x 27.68x 24.68x
PEG 4.04f 0.16f 2.03f
Net Asset Value PS -47.38p 61.80p 75.10p

mike740
02/6/2015
15:25
CVSG veterinary services, on the verge of a breakout and next leg up. Looks dear but EPS Increase next year with bolt ons.
mike740
23/5/2015
19:03
Lomax99

Big Thankyou for your post and well done here.CVS took on a huge debt to buy up these vets over the last 7 years and the market held the companies share price down as a result.As the debt has reduced and profits have gone up so has the share price.PVG looks to have had a cash shortage from day one and thus could not buy up other vets in any kind of numbers.You are also spot on with your view that the big two are going to keep on buying and expanding.CVS has seen its stock rise 200% over 7 years with rocket under the price over the last two.We will have to wait and see what PVG does but without the odd £100M plus being raised they don't have a chance in hell of buying up vets in the UK.A much safer and cheaper option would be to grow the pet plans and buying side of the group in quick order.PVG have just hired a director and talked about a global company. Have you any idea where UK vets sit in the world rankings.? In other words is the UK ahead or to the rear of other nations product / price and so on. Thanks from the hound and myself.

pet lover
23/5/2015
10:43
Pet lover. I will watch PVG with interest and may make an investment, interestingly I see from the prospectus that Gervais William's Miton group has a holding. I have been in CVS a long time, what attracted me was a large fragmented market ripe for consolidation, buying small practices on low PE multiples (with little alternative exit routes) and, efficiently, consolidating. CVS was originally VC funded, and aimed to employ more professional management once the industry was de-regulated, opening the prospect for non-vets to own & operate vets practices. CVS's regimented acquisitive growth has enabled it to reap economies of scale through efficiently managing the process, thereby transforming the underlying EBITDA performance of practices acquired, something they themselves could not hope to do. Pet Health plans, specialist laboratory services, online pharmacies, etc are all a logical extension to build brand loyalty and to seek/prevent leakage of extra margin.

I can see the network opportunity that PVG may have to target a generic pet health plan to the other 75% of the market, it will be interesting to see how it develops as I suspect the two lead consolidators will be looking to significantly increase their combined 25% share in the next few years - although there is probably plenty of scope for all to grow. I note reference in the PVG prospectus that their 15 practices had been an attempt by the previous management to act as a consolidator, it implies they had been largely unsuccessful at that - perhaps the new management will make a better fist of it, presumably however the main idea to focus on generic pet health plans for third party practices?

lomax99
22/5/2015
21:13
The pet plans make large profits and open the door to cross sell other product.The hound and I are on the look out for any company that can grow these plans at the kind of rates that CVS is doing right now. Denplan is another in the field. CVS can only sell those plans through its own vets so the total numbers of plans to be sold has a ceiling.I am not saying the pet plan growth here will slow any time soon just that their is a limit.
CVS is also growing profits in various other areas as you rightly say. PVG has got a different model selling pet health plans on behalf of other independent vets C 75% of the total market.PVG also has a buying group doing the same.To sum up if PVG can get 1,000 Vets selling its health plans over time it could take the cream of profits and margin without the massive costs of buying and running vets.Long term investors here ran the risk of very high debt in the early years but at the end of the day that proved the very time to invest. PVG is unknown it's even listed on the big board not on Aim. The hound and I want to mimic the returns here over the last few years. I would also like Mr Slater to take a look if he reads this.From the hound and myself night night.

pet lover
22/5/2015
20:33
The real attraction of this business is the cash generation and the ability to sell a growing number of ancillary services to customers as the number of core practices grows. While operating profit increased to £5.8m (2013: £3.8m) cash generated from operations was £12.9m (2013: £10.5m) and free cash generation £8.4m.


At the half year, the Practice Division operated 276 veterinary surgeries across the UK under a number of well-established local brands, primarily focused on the small animal market. Management estimates that CVS has an 11% share of the UK small animal veterinary market. The Group employed almost 3,000 people at the half year end

The £4.1m paid for acquisitions historically reflected EBITDA of approximately £1.1m, an attractive multiple.

Their Healthy Pet Club schemes have grown significantly with membership at 31 December 2014 in excess of 192,000 pets, an increase of almost 39% since December 2013. Income from Healthy Pet Club schemes represented 12.5% of the income of the Practice Division for the six month period up from 10.5% in the comparable period. The schemes offer discounted products and services aiming to improve clinical compliance levels amongst members and to protect practice sales by bonding pet owners to their local CVS surgery. Clearly as more practices are acquired there is a big opportunity to plug more clients into this.

lomax99.

Thankyou for your views I can agree in part but CVS Only made £5.8M from all those vets in 6 months.Profits for the company on the other hand went up by a very large amount as did the quality of those earnings. Those pet health plans added a full 2% points to the practice division. Profits have been going up in line with the rapid sale and take up of these health plans over the last few years.It can be seen that it's the add on's that are where the real growth is comming from.

pet lover
22/5/2015
18:50
I don't see the health pet plans being key to CVS TBH, they will however help build brand loyalty/aid retention. The key element to the CVS story is acting as an efficient consolidator in a highly fragmented market, with comparatively modest exit opportunities for retiring practice owners. Witness the modest acquisition highlighted in CVS's interims - they paid only £4.1M to obtain c. £1.1M of Ebitda(!), and that is before they streamline anything achieving economies of scale for procurement, central admin, etc, etc. The exciting thing is that the two lead consolidators still only account for c 25% of the market, so there is a very healthy pipeline indeed for future acquisitive growth.
lomax99
22/5/2015
08:21
I was wrong in thinking this share was overvalued one just has to look at the chart. The hound and I have done our research on these and the other two listed vets. Again I thought PETS was overvalued at its float price but has since done very well. The hound and I have gone for PVG as yet an unknown stock that came to the market through an rto in the spring. CVS is now a very large company with good management and I can see the stock hitting ten pounds within 3 to 4 years.If the truth be known I think the driving force for the profits here is due in part to the rise in its health pet plans. It's those plans that I have an idea will be the key at PVG as well.The sector as a whole is well liked for its stable cashflow.
pet lover
Chat Pages: Latest  14  13  12  11  10  9  8  7  6  5  4  3  Older

Your Recent History

Delayed Upgrade Clock